Determination of polyfluoroalkyl substances in cosmetic products using dispersed liquid–liquid extraction coupled with UHPLC-MS/MS
Literature Information
Wenyao Liang, Zemin Xia, Jianhua Tan
Human exposure to polyfluoroalkyl substances (PFASs) via cosmetics has been of increasing concern due to the tremendous detrimental health impacts of PFASs. Developing an effective method for extracting and determining PFASs in cosmetics is crucial in accurately assessing their corresponding human exposure risk. Herein, this study developed a new sample pre-treatment method to address the challenges posed by the variety and complexity of cosmetic matrices. Seventeen PFASs in cosmetic products, including 9 perfluoro carboxylic acids and 8 perfluorosulfonic acids, were simultaneously determined using ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS). The whole pre-treatment process can be divided into three steps. In step 1, cosmetics with diverse matrix types can be effectively dispersed during extraction by using saturated sodium chloride–acetonitrile and saturated sodium chloride–tetrahydrofuran as extraction solvents. In step 2, the pre-purification step employs a potassium ferrocyanide–zinc acetate co-precipitant to remove high molecular weight interferents from the extraction solution, thereby enhancing the efficiency of solid-phase extraction (SPE). In step 3, WAX-SPE is utilized to further eliminate interferents from the extraction solution while concentrating the analytes, meeting the trace analysis requirements for PFASs in cosmetics. The method detection limits were 0.09–0.26 ng g−1. The recoveries ranged from 70.1% to 114.7%, with relative standard deviations in the range of 2.0–19.1%. The method was applied to cosmetic samples in the Guangzhou market, and the total concentration of PFASs ranged from 0 to 10.8 ng g−1. This method has strong anti-interference ability, good applicability, high sensitivity, and good reproducibility, making it suitable for the analysis and detection of perfluorinated acids in cosmetic samples. It provides technical support for cosmetics safety regulation.
Related Literature
Role of the carbon source in the transformation of amorphous carbon to graphene during rapid thermal processing
Yong Zhou, Xiaowei Xu, Aiying Wang, Kwang-Ryeol Lee
DOI: 10.1039/C9CP01305A
Effect of density on the thermal decomposition mechanism of ε-CL-20: a ReaxFF reactive molecular dynamics simulation study
Fuping Wang, Lang Chen, Deshen Geng, Jianying Lu, Junying Wu
DOI: 10.1039/C8CP03010C
Enhancing high harmonic generation by the global optimization of a two-color chirped laser field
Mohammad Mofared, Elnaz Irani, Rasoul Sadighi-Bonabi
DOI: 10.1039/C8CP07619G
Solvation of 2-(hydroxymethyl)-2,5,7,8-tetramethyl-chroman-6-ol revealed by circular dichroism: a case of chromane helicity rule breaking
Joanna E. Rode, Marcin Górecki, Stanisław Witkowski, Jadwiga Frelek
DOI: 10.1039/C8CP02491J
Interband transitions in closed-shell vacancy containing graphene quantum dots complexed with heavy metals
Rositsa Yakimova
DOI: 10.1039/C8CP03306D
Quantum anomalous Hall effect in metal-bis(dithiolene), magnetic properties, doping and interfacing graphene
F. Crasto de Lima, Gerson J. Ferreira, R. H. Miwa
DOI: 10.1039/C8CP03792B
How does the electric current propagate through fully-hydrogenated borophene?
Jutao Jiao, Yusheng Hou, Hui Wang, Dapeng Wu, Tianxing Wang, Zhaoming Fu, Guoliang Xu, Ruqian Wu
DOI: 10.1039/C8CP04272A
Understanding the differences between iron and palladium in cross-coupling reactions
Xiaobo Sun, Trevor A. Hamlin
DOI: 10.1039/C8CP07671E
Assessing the performance of MM/PBSA and MM/GBSA methods. 9. Prediction reliability of binding affinities and binding poses for protein–peptide complexes
Gaoqi Weng, Ercheng Wang, Fu Chen, Huiyong Sun, Zhe Wang
DOI: 10.1039/C9CP01674K
Reply to the ‘Comment on “Negative effective Li transference numbers in Li salt/ionic liquid mixtures: does Li drift in the “Wrong” direction?”’ by K. R. Harris, Phys. Chem. Chem. Phys., 2018, 20, DOI: 10.1039/C8CP02595A
Monika Schönhoff, Cornelia Cramer, Florian Schmidt
DOI: 10.1039/C8CP06075D
You might also like
What are the main uses of 4-Nitrophenyl phosphate disodium salt hexahydrate (CAS: 333338-18-4)?
4-Nitrophenyl phosphate disodium salt hexahydrate is primarily used as a substra...
What are the main uses of 2-(Trifluoromethyl)-1,3-oxazole-4-carboxylic Acid (CAS: 1060816-01-4)?
2-(Trifluoromethyl)-1,3-oxazole-4-carboxylic Acid (CAS: 1060816-01-4) is widely ...
How should 2-Fluoro-4-biphenylcarboxylic acid (CAS: 137045-30-8) be stored?
2-Fluoro-4-biphenylcarboxylic acid should be stored in a cool, dry place at room...
What industries use Prednisolone-21-Carboxylic Acid (CAS: 61549-70-0)?
Prednisolone-21-Carboxylic Acid is primarily used in the pharmaceutical industry...
How should 4-(Hydrazinomethyl)-1,2,3-benzenetriol (CAS: 3614-72-0) be stored?
4-(Hydrazinomethyl)-1,2,3-benzenetriol (CAS: 3614-72-0) should be stored in a co...
What industries use 4-Amino-1-methyl-1H-pyrazole-5-carboxylic acid hydrochloride (CAS: 92534-70-8)?
4-Amino-1-methyl-1H-pyrazole-5-carboxylic acid hydrochloride (CAS: 92534-70-8) i...
What regulatory guidelines apply to dehydropachymic acid (CAS: 77012-31-8)?
Dehydropachymic acid (CAS: 77012-31-8) is regulated by various agencies. It fall...
What is the market or research trend for 6-[(2,2-Dimethylpropanoyl)amino]nicotinic acid (CAS: 898561-66-5)?
The market and research trends for 6-[(2,2-Dimethylpropanoyl)amino]nicotinic aci...
How should 1,10-Phenanthroline-2,9-dicarbaldehyde (CAS: 57709-62-3) be stored?
1,10-Phenanthroline-2,9-dicarbaldehyde should be stored in a cool, dry place awa...
How is 5-Carbamoyl-11-oxo-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate (CAS: 113952-21-9) typically synthesized?
5-Carbamoyl-11-oxo-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate can be synt...
Source Journal
Analytical Methods

Analytical Methods welcomes early applications of new analytical and bioanalytical methods and technology demonstrating the potential for societal impact. We require that methods and technology reported in the journal are sufficiently innovative, robust, accurate, and compared to other available methods for the intended application. Developments with interdisciplinary approaches are particularly welcome. Systems should be proven with suitably complex and analytically challenging samples. We encourage developments within, but not limited to, the following technologies and applications: global health, point-of-care and molecular diagnostics biosensors and bioengineering drug development and pharmaceutical analysis applied microfluidics and nanotechnology omics studies, such as proteomics, metabolomics or glycomics environmental, agricultural and food science neuroscience biochemical and clinical analysis forensic analysis industrial process and method development










![N-[2-(4-Hydroxyphenoxy)-4-nitrophenyl]methanesulfonamide structure N-[2-(4-Hydroxyphenoxy)-4-nitrophenyl]methanesulfonamide structure](https://static.chemtradehub.com/structs/109/109032-22-6-7c88.webp)

![(3R,5R)-1-[(Benzyloxy)carbonyl]-5-methyl-3-piperidinecarboxylic acid structure (3R,5R)-1-[(Benzyloxy)carbonyl]-5-methyl-3-piperidinecarboxylic acid structure](https://static.chemtradehub.com/structs/126/1269757-29-0-c552.webp)

phosphoryl}methyl 4-methylbenzenesulfonate structure {[3-(Hexadecyloxy)propoxy](hydroxy)phosphoryl}methyl 4-methylbenzenesulfonate structure](https://static.chemtradehub.com/structs/864/864068-45-1-ba7c.webp)